Literature DB >> 18646507

Continuous renal replacement therapy for the treatment of acute kidney injury.

Woo Kvun Bae1, Dae Hun Lim, Ji Min Jeong, Hae Young Jung, Seong Ku Kim, Jeong Woo Park, Eun Hui Bae, Seong Kwon Ma, Soo Wan Kim, Nam Ho Kim, Ki Chul Choi.   

Abstract

BACKGROUND/AIMS: Continuous renal replacement therapy (CRRT) has been widely used for treating critically ill patients with acute kidney injury (AKI). Whether CRRT is better than intermittent hemodialysis for the treatment of AKI remains controversial. We sought to identify the clinical features that can predict survival for the patients who are treated with CRRT.
METHODS: We analyzed the data of 125 patients who received CRRT between 2005 and 2007. We identified the demographic variables, the underlying diagnoses, the duration of CRRT, the mean arterial blood pressure (ABP) and the Simplified Acute Physiology Score (SAPS) II. The classification/staging system for acute kidney injury (AKI) was applied to all the patients, who were then divided into stage 1-3 subgroups.
RESULTS: The average age of the patients was 61.414.3 years and the mortality rate was 60% (75 of 125 patients). The survivors had a significantly higher mean ABP and a higher mean serum bicarbonate level, which were measured the day after CRRT, than the nonsurvivors (86.723.7 vs. 69.224.6 mm Hg, respectively, 21.43.5 vs. 16.45.4 mmol/L, respectively,; p<0.05 for each). The stage 3 AKI patients showed the worst parameters for the SAPS II score and the serum levels of creatinine and blood urea nitrogen. The mortality rate was higher for the stage 3 subgroup than the other groups (70.5%, p<0.05).
CONCLUSIONS: The patients with AKI and who require CRRT continue to have a high mortality rate. A higher mean ABP and a higher serum bicarbonate level measured the day after CRRT may predict a more favorable prognosis. The staging system for AKI can improve the ability to predict the outcomes of CRRT patients.

Entities:  

Mesh:

Year:  2008        PMID: 18646507      PMCID: PMC2686975          DOI: 10.3904/kjim.2008.23.2.58

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   3.165


  17 in total

1.  Current Canadian approaches to dialysis for acute renal failure in the ICU.

Authors:  A Hyman; D C Mendelssohn
Journal:  Am J Nephrol       Date:  2002 Jan-Feb       Impact factor: 3.754

2.  The role of intensive dialysis in acute renal failure.

Authors:  D M Gillum; B S Dixon; M J Yanover; S P Kelleher; M D Shapiro; R G Benedetti; M A Dillingham; M S Paller; J P Goldberg; R C Tomford
Journal:  Clin Nephrol       Date:  1986-05       Impact factor: 0.975

Review 3.  The Acute Dialysis Quality Initiative--part II: patient selection for CRRT.

Authors:  Rinaldo Bellomo; Derek Angus; Robert A Star
Journal:  Adv Ren Replace Ther       Date:  2002-10

4.  Survival to discharge among patients treated with continuous renal replacement therapy.

Authors:  Ron Wald; Rushi Deshpande; Chaim M Bell; Joanne M Bargman
Journal:  Hemodial Int       Date:  2006-01       Impact factor: 1.812

5.  The outcome of acute renal failure in the intensive care unit according to RIFLE: model application, sensitivity, and predictability.

Authors:  Nihal Y Abosaif; Yasser A Tolba; Mike Heap; Jean Russell; A Meguid El Nahas
Journal:  Am J Kidney Dis       Date:  2005-12       Impact factor: 8.860

6.  Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure.

Authors:  R D Swartz; J M Messana; S Orzol; F K Port
Journal:  Am J Kidney Dis       Date:  1999-09       Impact factor: 8.860

7.  Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia.

Authors:  W Silvester; R Bellomo; L Cole
Journal:  Crit Care Med       Date:  2001-10       Impact factor: 7.598

8.  [Arteriovenous haemofiltration: a new and simple method for treatment of over-hydrated patients resistant to diuretics].

Authors:  P Kramer; W Wigger; J Rieger; D Matthaei; F Scheler
Journal:  Klin Wochenschr       Date:  1977-11-15

9.  Spectrum of acute renal failure in the intensive care unit: the PICARD experience.

Authors:  Ravindra L Mehta; Maria T Pascual; Sharon Soroko; Brandon R Savage; Jonathan Himmelfarb; T Alp Ikizler; Emil P Paganini; Glenn M Chertow
Journal:  Kidney Int       Date:  2004-10       Impact factor: 10.612

10.  Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients.

Authors:  Philipp G H Metnitz; Claus G Krenn; Heinz Steltzer; Thomas Lang; Jürgen Ploder; Kurt Lenz; Jean-Roger Le Gall; Wilfred Druml
Journal:  Crit Care Med       Date:  2002-09       Impact factor: 7.598

View more
  4 in total

1.  Continuous renal replacement therapy versus furosemide for management of kidney impairment in heart transplant recipients with volume overload.

Authors:  Seyed Mohsen Mirhosseini; Mohammad Fakhri; Shadi Asadollahi; Zargham Hossein Ahmadi; Farin Rashid Farokhi; Mohammad Reza Boloursaz; Mohammad Reza Masjedi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12-05

2.  Cumulative fluid balance and mortality in elderly patients with acute kidney injury requiring continuous renal-replacement therapy: a multicenter prospective cohort study.

Authors:  Jong Hyun Jhee; Jae Yoon Park; Jung Nam An; Dong Ki Kim; Kwon Wook Joo; Yun Kyu Oh; Chun Soo Lim; Yon Su Kim; Seung Hyeok Han; Tae-Hyun Yoo; Shin-Wook Kang; Jung Pyo Lee; Jung Tak Park
Journal:  Kidney Res Clin Pract       Date:  2020-12-31

3.  Risk factors for mortality in patients with acute kidney injury and hypotension treated with continuous veno-venous hemodiafiltration.

Authors:  In Myung Oh; Jang Han Lee; Kyoung Hwa Yoo; Ji Eun Park; Dong Hyun Oh; Mi Jung Kim; Seung Hea Ha; Gi Jong Lee; Jung Hee Kim; Yoon Chul Jung
Journal:  Kidney Res Clin Pract       Date:  2012-10-05

4.  Factors Associated with Early Mortality in Critically Ill Patients Following the Initiation of Continuous Renal Replacement Therapy.

Authors:  Youn Kyung Kee; Dahye Kim; Seung-Jung Kim; Duk-Hee Kang; Kyu Bok Choi; Hyung Jung Oh; Dong-Ryeol Ryu
Journal:  J Clin Med       Date:  2018-10-08       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.